CMPR Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Cimpress PLC (CMPR) is not a strong buy at the moment for a beginner investor with a long-term strategy. While hedge funds are showing increased interest and analysts have raised price targets with positive ratings, the company's financial performance shows declining net income, EPS, and gross margin. Additionally, technical indicators suggest a neutral trend, and there are no strong proprietary trading signals or recent news catalysts to support an immediate buy decision.
The MACD histogram is -0.211, below 0, and negatively contracting, indicating a bearish trend. RSI is neutral at 51.563, suggesting no clear momentum. Moving averages are converging, showing no strong directional trend. Key support is at 69.049, and resistance is at 73.897, with the stock price currently near the pivot level of 71.473.
Hedge funds are significantly increasing their positions in CMPR, with a 155.46% increase in buying activity last quarter. Analysts have raised price targets to $95 and $100, citing strong Q2 results and raised FY26 guidance.
The company's financial performance in Q2 2026 shows a decline in net income (-19.18% YoY), EPS (-17.37% YoY), and gross margin (-1.77% YoY). Technical indicators are neutral to slightly bearish, and there are no recent news or significant insider trading trends to act as a catalyst.
In Q2 2026, revenue increased by 10.97% YoY to $1.042 billion, but net income dropped by 19.18% YoY to $49.34 million. EPS declined by 17.37% YoY to $1.95, and gross margin decreased slightly to 46.52%. This mixed performance highlights growth in revenue but challenges in profitability.
Analysts are optimistic, with Barrington raising the price target to $95 and Truist raising it to $100, both maintaining positive ratings. Analysts highlight strong Q2 results, sustained demand for higher-value offerings, and stabilization in legacy products.
